Lunit to Present 5 Abstracts at the 2023 AACR Annual Meeting
- Written by PR Newswire
![]() |
- Five posters from Lunit and collaborators demonstrate important progress in the development of novel diagnostics for important cancer therapies, including immunotherapy
SEOUL, South Korea, March 15, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer solutions, today announced its participation in the American...
Read more: Lunit to Present 5 Abstracts at the 2023 AACR Annual Meeting